For Immediate Release Chicago, IL – April 16, 2025 – Stocks in this week’s article are — like Alibaba Group BABA, Fresenius Medical Care AG FMS, Helix Energy Solutions Group Inc. HLX and Heritage Insurance Holdings, Inc. HRTG. 4 Top-Ranked High-Earnings-Yield Value Stocks to Buy Right Away President Trump’s announcement of reciprocal tariffs, followed by a 90-day pause, caused major swings in the U.S. stock market. The S&P 500 dropped 9% in the first week of April, marking its worst week since 2020. It then rebounded 5.7% the next week, the best since 2023. A major one-day gain came last Wednesday after Trump paused most tariffs, which boosted investor confidence. Yesterday, markets were lifted by exemptions from reciprocal tariffs on items like smartphones, semiconductors and solar cells. This led to a strong tech rally and extended last week’s gains. However, the S&P 500 remained below its level from April 2, before the tariffs were announced. Uncertainty around a potential global trade war still worries investors and economists. In such volatile times, value investing stands out as a smart, stable strategy for long-term gains. Alibaba Group, Fresenius Medical Care AG, Helix Energy Solutions Group Inc. and Heritage Insurance Holdings, Inc. are a few solid high-value picks with high earnings yields. Power Up Your Portfolio Value With Earnings Yield Metric Value investing means buying stocks that are priced below what they are really worth. It works on the idea that markets often misprice stocks, giving investors a chance to buy low and profit later. One simple tool value investors use is earnings yield. It shows how much profit a company makes for each dollar of its stock price. Earnings yield, expressed in percentage, is calculated as (Annual Earnings per Share/Market Price) x 100. It is the reverse of the price-to-earnings (P/E) ratio. A high earnings yield may mean the stock is undervalued. A low yield could mean the stock is too expensive. Investors can also use earnings yield to compare stocks with bond returns like the 10-year Treasury yield. If the stock market's earnings yield is higher than the bond yield, stocks might be more attractive. With regard to this, earnings yield can be more illuminating than the traditional P/E ratio, as the former facilitates the comparison of stocks with fixed-income securities. Our Picks Here we discuss four of the 42 stocks that qualified the screening: Alibaba: The company has cemented its position as the undisputed e-commerce powerhouse in China and is rapidly expanding its international presence. Alibaba operates through seven segments — China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. Story Continues The Zacks Consensus Estimate for BABA’s fiscal 2025 and 2026 earnings implies year-over-year growth of 2.1% and 23%, respectively. EPS estimates for the current and next fiscal year have moved up by 8 cents and 59 cents, respectively, over the past 60 days. Alibaba currently sports a Zacks Rank #1 and has a Value Score of B. Fresenius Medical: It is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure. Fresenius Medical recently launched the newest version of its home dialysis machine, NxStage Versi HD with GuideMe Software. The Zacks Consensus Estimate for FMS’ 2025 and 2026 earnings implies year-over-year growth of 27.1% and 9.1%, respectively. EPS estimates for the current and next year have moved up by 10 cents and 9 cents, respectively, over the past 30 days. Fresenius Medical currently sports a Zacks Rank #1 and has a Value Score of A. HelixEnergy: It is an international offshore energy company. Helix Energy provides specialty services to the offshore energy industry, with a focus on their growing well intervention and robotics operations. The Zacks Consensus Estimate for HLX’s 2025 and 2026 earnings implies year-over-year growth of 42% and 28.2%, respectively. EPS estimates for the current and next year have moved up by 12 cents and 14 cents, respectively, over the past 60 days. Helix Energy currently sports a Zacks Rank #1 and has a Value Score of A. Heritage Insurance: It provides personal and commercial residential insurance products. Heritage Insurance’s focus on rate adequacy, selective underwriting and profit-oriented underwriting criteria while restricting new business in over-concentrated markets or products poises it well for growth. The Zacks Consensus Estimate for HRTG’s 2025 and 2026 earnings implies year-over-year growth of 21% and 28.6%, respectively. EPS estimates for the current and next year have moved up by 64 cents and 73 cents, respectively, over the past 60 days. Heritage Insurance currently sports a Zacks Rank #1 and has a Value Score of A. You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2449125/4-top-ranked-high-earnings-yield-value-stocks-to-buy-right-away Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Zacks.com Phone: 312-265-9268 Email: [email protected] Visit: https://www.zacks.com/ Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS):Free Stock Analysis Report Helix Energy Solutions Group, Inc. (HLX):Free Stock Analysis Report Alibaba Group Holding Limited (BABA):Free Stock Analysis Report Heritage Insurance Holdings, Inc. (HRTG):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Zacks.com featured highlights include Alibaba, Fresenius Medical, Helix Energy Solutions and Heritage Insurance
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...